The value of some study drugs can reach tens of millions of dollars, making it essential to avoid overproduction, oversupply, and inventory expiration. With the high costs and strict handling requirements for many biopharmaceutical products entering clinical development, the logistics of clinical trial supplies are more critical than ever.
Streamlined clinical trial supply processes, led by your assigned provider, have the experience and expertise to make sure your study drug is where you need it when you need it. Expert management begins with the clinical trial supply strategy, and ends with returns and destruction. Integration and coordination of many third-party vendors and technical systems is needed to verify that study drugs are available in sufficient quantity and quality at the various stages of clinical distribution.
Investigational Medicinal Products (IMPs) must be manufactured, stored and distributed in strict accordance with Good Manufacturing Practices, utilizing labeling and packaging that match the trial protocol.
Equally important is the importation and distribution of IMPs and Non Investigational Products (NIMPs) — such as rescue and add-on medication — that require extensive planning.
Oxford Compounding Clinical Trial provides the knowledge and action to ensure deliveries are not delayed and to decrease the risk of expired inventory.
Our focus is providing the best possible treatments available to patients